At 4.0% CAGR, the Europe Embolization Coils Market is projected to be worth US$ 391.22 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Europe embolization coils market was valued at US$ 310.02 million in 2022 and is expected to reach US$ 391.22 million by 2028, registering a CAGR of 4.0% from 2022 to 2028. Increase in prevalence of cardiac aneurysm and growth in incidence of cancer cases are the critical factors attributed to the Europe embolization coils market expansion.

Hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Kidney cancer is becoming more common in people of all ages and races, having different tumor sizes. Hypertension, obesity, and smoking are all risk factors for kidney cancer. Obesity is associated with high blood pressure, dyslipidemia, diabetes or insulin resistance, and higher fibrinogen and C-reactive protein levels, which also increase the risk of cardiovascular diseases (CVDs). The increasing prevalence of such diseases is fueling the demand for embolization coils. Bariatric embolization is a new endovascular technique to cure patients with obesity. Bariatric embolization carries embolic microspheres into the gastric arteries to induce localized ischemia and has modified appetite hormones, leading to reduced weight. Thus, the increasing prevalence of hypertension, smoking, alcoholism, and obesity is supporting the growth of the embolization coils market. Chronic diseases, such as heart disease, stroke, cancer, diabetes, and obesity, are the leading causes of death in the Europe and account for most of the nation’s health care costs. This is expected to drive the market during the forecast period.

On the contrary, high price of embolization coils hurdles the growth of Europe embolization coils market. 

Based on type, the Europe embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held 58.0% market share in 2022, amassing US$ 179.68 million. It is projected to garner US$ 231.22 million by 2028 to expand at 4.3% CAGR during 2022–2028.

Based on material, the Europe embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held 45.2% market share in 2022, amassing US$ 140.27 million. It is projected to garner US$ 181.74 million by 2028 to expand at 4.4% CAGR during 2022–2028.

Based on application, the Europe embolization coils market is categorized into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held 29.2% market share in 2022, amassing US$ 90.42 million. It is projected to garner US$ 118.69 million by 2028 to expand at 4.6% CAGR during 2022–2028.

Based on end user, the Europe embolization coils market is categorized into hospital, cardiac center, ambulatory center, and other. The hospital segment held 55.2% market share in 2022, amassing US$ 171.02 million. It is projected to garner US$ 221.69 million by 2028 to expand at 4.4% CAGR during 2022–2028.

Based on country, the Europe embolization coils market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe.  Our regional analysis states that Germany captured 27.6% market share in 2022. It was assessed at US$ 85.50 million in 2022 and is likely to hit US$ 109.03 million by 2028, exhibiting a CAGR of 4.1% during the forecast period.            

Key players dominating the Europe embolization coils market are Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. among others.

• In Aug 2022, Boston Scientific (BSX) Signs Obsidio-Acquisition Agreement.
• In Dec 2019, Kaneka releases a new coil for embolization of brain aneurysms.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com